Published in Nucleic Acids Res on May 17, 2011
MicroRNAs in heart development. Curr Top Dev Biol (2012) 1.06
A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness. Oncotarget (2015) 0.86
Genome-Wide Anaplasma phagocytophilum AnkA-DNA Interactions Are Enriched in Intergenic Regions and Gene Promoters and Correlate with Infection-Induced Differential Gene Expression. Front Cell Infect Microbiol (2016) 0.77
Epigenetic deregulation of microRNAs in rhabdomyosarcoma and neuroblastoma and translational perspectives. Int J Mol Sci (2012) 0.76
Genomic regions targeted by DNA topoisomerase IIβ frequently interact with a nuclear scaffold/matrix protein hnRNP U/SAF-A/SP120. J Cell Biochem (2015) 0.75
High-throughput cis-regulatory element discovery in the vector mosquito Aedes aegypti. BMC Genomics (2016) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
MicroRNA signatures in human cancers. Nat Rev Cancer (2006) 46.29
Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008) 37.16
Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet (2005) 15.96
Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat Rev Genet (2001) 11.70
Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov (2010) 6.07
ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res (2004) 4.99
Visualization of replication factories attached to nucleoskeleton. Cell (1993) 3.36
Supercoiled loops and eucaryotic DNA replicaton. Cell (1980) 3.24
SATB1 targets chromatin remodelling to regulate genes over long distances. Nature (2002) 3.10
Two functionally distinct forms of the RSC nucleosome-remodeling complex, containing essential AT hook, BAH, and bromodomains. Mol Cell (1999) 2.76
Conserved CTCF insulator elements flank the mouse and human beta-globin loci. Mol Cell Biol (2002) 2.69
Metaphase chromosome structure: bands arise from a differential folding path of the highly AT-rich scaffold. Cell (1994) 2.60
Biological significance of unwinding capability of nuclear matrix-associating DNAs. Science (1992) 2.41
SAR-dependent mobilization of histone H1 by HMG-I/Y in vitro: HMG-I/Y is enriched in H1-depleted chromatin. EMBO J (1993) 2.27
The nuclear matrix: a structural milieu for genomic function. Int Rev Cytol (1995) 2.05
Analysis of the attachment of replicating DNA to a nuclear matrix in mammalian interphase nuclei. Nucleic Acids Res (1979) 1.91
Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J Clin Invest (2007) 1.72
Transcriptional augmentation: modulation of gene expression by scaffold/matrix-attached regions (S/MAR elements). Crit Rev Eukaryot Gene Expr (2000) 1.54
Chromatin loops are selectively anchored using scaffold/matrix-attachment regions. J Cell Sci (2004) 1.51
The activity of mammalian brm/SNF2alpha is dependent on a high-mobility-group protein I/Y-like DNA binding domain. Mol Cell Biol (1999) 1.48
HMGA and cancer. Biochim Biophys Acta (2010) 1.45
A structural analysis of the role of the nuclear matrix and DNA loops in the organization of the nucleus and chromosome. J Cell Sci Suppl (1984) 1.43
The nuclear matrix: a heuristic model for investigating genomic organization and function in the cell nucleus. J Cell Biochem (1991) 1.41
Mathematical model to predict regions of chromatin attachment to the nuclear matrix. Nucleic Acids Res (1997) 1.41
A significant fraction of conserved noncoding DNA in human and mouse consists of predicted matrix attachment regions. Trends Genet (2003) 1.39
The genomic sequences bound to special AT-rich sequence-binding protein 1 (SATB1) in vivo in Jurkat T cells are tightly associated with the nuclear matrix at the bases of the chromatin loops. J Cell Biol (1998) 1.37
The role of SATB1 in breast cancer pathogenesis. J Natl Cancer Inst (2010) 1.36
From DNA structure to gene expression: mediators of nuclear compartmentalization and dynamics. Chromosome Res (2003) 1.17
Nuclear matrix interactions at the human protamine domain: a working model of potentiation. J Biol Chem (2004) 1.16
Structure and function of the HMGI(Y) family of architectural transcription factors. Environ Health Perspect (2000) 1.11
Chromatin domains and nuclear compartments: establishing sites of gene expression in eukaryotic nuclei. Mol Biol Rep (1997) 1.06
Binding of HMG-I(Y) imparts architectural specificity to a positioned nucleosome on the promoter of the human interleukin-2 receptor alpha gene. Mol Cell Biol (2000) 1.04
Gene regulation by SMAR1: Role in cellular homeostasis and cancer. Biochim Biophys Acta (2010) 1.02
Differential nuclear scaffold/matrix attachment marks expressed genes. Hum Mol Genet (2008) 1.01
HMG I/Y regulates long-range enhancer-dependent transcription on DNA and chromatin by changes in DNA topology. Nucleic Acids Res (2000) 0.97
Involvement of the nuclear matrix in the control of skeletal genes: the NMP1 (YY1), NMP2 (Cbfa1), and NMP4 (Nmp4/CIZ) transcription factors. Crit Rev Eukaryot Gene Expr (2001) 0.93
MARs and MARBPs: key modulators of gene regulation and disease manifestation. Subcell Biochem (2007) 0.92
Re-defining the chromatin loop domain. Cytogenet Cell Genet (2001) 0.91
Performance of genomic bordering elements at predefined genomic loci. Mol Cell Biol (2005) 0.90
Computer-assisted search for sites of nuclear matrix attachment. Genomics (1996) 0.89
Reconfiguration of genomic anchors upon transcriptional activation of the human major histocompatibility complex. Genome Res (2008) 0.88
HIV-1 integration sites are flanked by potential MARs that alone can act as promoters. Biochem Biophys Res Commun (2004) 0.82
HMGA molecules in neuroblastic tumors. Ann N Y Acad Sci (2004) 0.81
Linking chromatin architecture to cellular phenotype: BUR-binding proteins in cancer. J Cell Biochem Suppl (2000) 0.78
Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J Clin Invest (2007) 2.28
Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians. Diabetes (2010) 2.16
Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells (2006) 2.07
Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: implication for increased monocyte transmigration. Blood (2010) 1.44
Network properties of complex human disease genes identified through genome-wide association studies. PLoS One (2009) 1.42
Genome-wide association study for type 2 diabetes in Indians identifies a new susceptibility locus at 2q21. Diabetes (2012) 1.40
Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation. EMBO J (2003) 1.27
Network modeling of the transcriptional effects of copy number aberrations in glioblastoma. Mol Syst Biol (2011) 1.26
Modulation of BMP signaling by noggin is required for induction of the secondary (nontylotrich) hair follicles. J Invest Dermatol (2002) 1.25
Genetic variants of FOXA2: risk of type 2 diabetes and effect on metabolic traits in North Indians. J Hum Genet (2008) 1.17
Bone morphogenetic protein (BMP) signaling controls hair pigmentation by means of cross-talk with the melanocortin receptor-1 pathway. Proc Natl Acad Sci U S A (2004) 1.10
Expression of deltaNp73 predicts poor prognosis in lung cancer. Clin Cancer Res (2004) 1.09
p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression. J Biol Chem (2002) 1.09
Obesity-dependent association of TNF-LTA locus with type 2 diabetes in North Indians. J Mol Med (Berl) (2010) 1.04
Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis. Am J Pathol (2004) 1.00
High-sensitivity C-reactive protein levels and type 2 diabetes in urban North Indians. J Clin Endocrinol Metab (2009) 0.99
TLX activates MASH1 for induction of neuronal lineage commitment of adult hippocampal neuroprogenitors. Mol Cell Neurosci (2010) 0.99
Highly interconnected genes in disease-specific networks are enriched for disease-associated polymorphisms. Genome Biol (2012) 0.98
p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y. J Biol Chem (2002) 0.98
ASK1 inhibits astroglial development via p38 mitogen-activated protein kinase and promotes neuronal differentiation in adult hippocampus-derived progenitor cells. Mol Cell Biol (2004) 0.98
Platelet-derived growth factor-mediated induction of the synaptic plasticity gene Arc/Arg3.1. J Biol Chem (2010) 0.94
The PDGF B-chain is involved in the ontogenic susceptibility of the developing rat brain to NMDA toxicity. Exp Neurol (2004) 0.94
Association analysis of TNFRSF1B polymorphisms with type 2 diabetes and its related traits in North India. Genomic Med (2009) 0.93
Human inositol polyphosphate multikinase regulates transcript-selective nuclear mRNA export to preserve genome integrity. Mol Cell (2013) 0.92
MicroRNAs act complementarily to regulate disease-related mRNA modules in human diseases. RNA (2013) 0.92
Characterization of neuroprogenitor cells expressing the PDGF beta-receptor within the subventricular zone of postnatal mice. Mol Cell Neurosci (2007) 0.92
Nuclear orphan receptor TLX induces Oct-3/4 for the survival and maintenance of adult hippocampal progenitors upon hypoxia. J Biol Chem (2010) 0.89
Gene prioritization in Type 2 Diabetes using domain interactions and network analysis. BMC Genomics (2010) 0.88
p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF beta-receptor. J Cell Sci (2004) 0.87
Hypercholesterolemia leads to elevated TGF-beta1 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice. Atherosclerosis (2008) 0.87
Exogenous introduction of tissue inhibitor of metalloproteinase 2 reduces accelerated growth of TGF-β-disrupted diffuse-type gastric carcinoma. Cancer Sci (2010) 0.86
pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription. J Cell Sci (2004) 0.86
BMP-6 and retinoic acid synergistically differentiate the IMR-32 human neuroblastoma cells. Anticancer Res (2003) 0.86
Mechanism of MASH1 induction by ASK1 and ATRA in adult neural progenitors. Mol Cell Neurosci (2007) 0.85
Platelet-derived growth factor-B and -C and active alpha-receptors in medulloblastoma cells. Biochem Biophys Res Commun (2002) 0.85
Kinetics of repression by modified p53 on the PDGF beta-receptor promoter. Int J Cancer (2008) 0.84
Genetic association, post-translational modification, and protein-protein interactions in Type 2 diabetes mellitus. Mol Cell Proteomics (2005) 0.82
Common variants in CRP and LEPR influence high sensitivity C-reactive protein levels in North Indians. PLoS One (2011) 0.81
Opposing effects of retinoid signaling on astrogliogenesis in embryonic day 13 and 17 cortical progenitor cells. J Neurochem (2008) 0.81
Dysregulation of platelet-derived growth factor beta-receptor expression by DeltaNp73 in neuroblastoma. Mol Cancer Res (2009) 0.80
Ischemia-induced renal expression of hyaluronan and CD44 in diabetic rats. Nephron Exp Nephrol (2006) 0.80
Neuroblastoma-specific cytotoxicity mediated by the Mash1-promoter and E. coli purine nucleoside phosphorylase. Pediatr Blood Cancer (2005) 0.80
TLX controls angiogenesis through interaction with the von Hippel-Lindau protein. Biol Open (2012) 0.80
Allelic heterogeneity of molecular events in human coagulation factor IX in Asian Indians. Mutation in brief #965. Online. Hum Mutat (2007) 0.79
Activity of a novel PDGF beta-receptor enhancer during the cell cycle and upon differentiation of neuroblastoma. Exp Cell Res (2006) 0.77
Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene. Haematologica (2004) 0.77
Delta Np73 expression in thyroid neoplasms originating from follicular cells. Pathology (2006) 0.76